By Josh Beckerman

Shares of Synergy Pharmaceuticals Inc. (SGYP), which filed for bankruptcy last week, recently traded up 55% to 12 cents as the company's flagship product Trulance was accepted for review by Health Canada.

Cipher Pharmaceuticals Inc. (CPH.T) bought Canadian rights to the constipation drug in Februrary.

Synergy filed for chapter 11 on Dec. 12 with a plan to sell its assets to Bausch Health Companies Inc. (BHC) for about $200 million in cash.

Write to Josh Beckerman at josh.beckerman@wsj.com

(END) Dow Jones Newswires

December 17, 2018 15:28 ET (20:28 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.
Synergy Pharmaceuticals, Inc. (MM) (NASDAQ:SGYPD)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Synergy Pharmaceuticals, Inc. (MM) Charts.
Synergy Pharmaceuticals, Inc. (MM) (NASDAQ:SGYPD)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Synergy Pharmaceuticals, Inc. (MM) Charts.